¿Qué es la vigilancia activa en patología tumoral maligna tiroidea? ¿Cuáles son las barreras para implementarla ampliamente en la Argentina?
Barra lateral del artículo
Contenido principal del artículo
Resumen
.
Downloads
Detalles del artículo
Sección
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
Cómo citar
Referencias
Sugitani I, Toda K, Yamada K, et al. Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes. World J Surg 2010;34:1222- 1231. DOI: https://doi.org/10.1007/s00268-009-0359-x
Ito Y, Miyauchi A, Kihara M, et al. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid 2014; 24:27-34. DOI: https://doi.org/10.1089/thy.2013.0367
Oda H, Miyauchi A, Ito Y, et al. Incidences of Unfavorable Events in the Management of Low-Risk Papillary Microcarcinoma of the Thyroid by Active Surveillance Versus Immediate Surgery. Thyroid 2016;26:150-155. DOI: https://doi.org/10.1089/thy.2015.0313
Kwon H, Oh HS, Kim M, et al. Active Surveillance for Patients With Papillary Thyroid Microcarcinoma: A Single Center's Experience in Korea. J Clin Endocrinol Metab 2017;102:1917-1925. DOI: https://doi.org/10.1210/jc.2016-4026
Tuttle RM, Fagin JA, Minkowitz G, et al. Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance. JAMA Otolaryngol Head Neck Surg 2017; 143:1015-1020. DOI: https://doi.org/10.1001/jamaoto.2017.1442
Ramundo V, Sponziello M, Falcone R, et al. Low-risk papillary thyroid microcarcinoma: Optimal management toward a more conservative approach. J Surg Oncol 2020; 121:958-963. DOI: https://doi.org/10.1002/jso.25848
Sakai T, Sugitani I, Ebina A, et al. Active Surveillance for T1bN0M0 Papillary Thyroid Carcinoma. Thyroid 2019; 29:59- 63 DOI: https://doi.org/10.1089/thy.2018.0462
Smulever A, Pitoia F. Active surveillance in papillary thyroid carcinoma: not easily accepted but possible in Latin America. Arch Endocrinol Metab 2019; 63:462-469. DOI: https://doi.org/10.20945/2359-3997000000168
Molinaro E, Campopiano MC, Pieruzzi L, et al. Active Surveillance in Papillary Thyroid Microcarcinomas is Feasible and Safe: Experience at a Single Italian Center. J Clin Endocrinol Metab 2020;105(3): e172-e180. DOI: https://doi.org/10.1210/clinem/dgz113
BIBLIOGRAFÍA
- Smulever A, Pitoia F. High rate incidence of post-surgical adverse events in patients with low-risk papillary thyroid cancer who did not accept active surveillance. Endocrine. 2020; 69(3):587-59. DOI: https://doi.org/10.1007/s12020-020-02310-8
- Pitoia F, Smulever A. “Vigilancia activa encubierta” y los costos de la ausencia de implementación de la “cirugía diferida” en Argentina. Rev Arg